Greater utility of molecular subtype rather than epithelial‐to‐mesenchymal transition ( EMT ) markers for prognosis in high‐risk non‐muscle‐invasive ( HGT1 ) bladder cancer
出版年份 2020 全文链接
标题
Greater utility of molecular subtype rather than epithelial‐to‐mesenchymal transition (
EMT
) markers for prognosis in high‐risk non‐muscle‐invasive (
HGT1
) bladder cancer
作者
关键词
-
出版物
Journal of Pathology Clinical Research
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-05-06
DOI
10.1002/cjp2.167
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Therapeutic implications of cancer epithelial-mesenchymal transition (EMT)
- (2019) Eunae Sandra Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer
- (2019) Mathieu Rouanne et al. EUROPEAN JOURNAL OF CANCER
- The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)
- (2019) Shahin De Lara et al. BMC CANCER
- EMT and Cancer: More Than Meets the Eye
- (2019) Rik Derynck et al. DEVELOPMENTAL CELL
- Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA
- (2019) Daley S. Morera et al. JOURNAL OF UROLOGY
- Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival
- (2019) Petter Kollberg et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
- (2019) Charles C. Guo et al. Cell Reports
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
- (2019) Marko Babjuk et al. EUROPEAN UROLOGY
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- Staging of bladder cancer
- (2018) Martin J Magers et al. HISTOPATHOLOGY
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition
- (2016) Joseph Sanfrancesco et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach
- (2016) Wolfgang Otto et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Fully Automated RNAscope In Situ Hybridization Assays for Formalin-Fixed Paraffin-Embedded Cells and Tissues
- (2016) Courtney M. Anderson et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
- (2016) Andrea E. Ochoa et al. Oncotarget
- Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
- (2016) Vipulkumar Dadhania et al. EBioMedicine
- New Insights into the Crossroads between EMT and Stemness in the Context of Cancer
- (2016) Isabel Fabregat et al. Journal of Clinical Medicine
- FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines
- (2016) Joshua I. Warrick et al. Scientific Reports
- Expression profile of epithelial-mesenchymal transition markers in non–muscle-invasive urothelial carcinoma of the bladder: Correlation with intravesical recurrence following transurethral resection
- (2015) Bing Liu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
- (2014) T Yoshida et al. BRITISH JOURNAL OF CANCER
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Domain and Functional Analysis of a Novel Breast Tumor Suppressor Protein, SCUBE2
- (2011) Yuh-Charn Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma
- (2010) Xianzhou Song et al. CANCER
- Expression of transcription factors snail, slug, and twist in human bladder carcinoma
- (2010) Qinchao Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
- (2010) K Vuoriluoto et al. ONCOGENE
- An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer
- (2009) Girish S. Kulkarni et al. EUROPEAN UROLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
- (2009) C. Gjerdrum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started